First sighting of rare spotted ground thrush in Palm Lakes
During a ringing event at the eco-estate on June 1, founders of The LionHeart Experience, Richard and Candice McKibbin – along with other environmentalists – caught and ringed the elusive spotted ground thrush.
This follows months of work by the husband-and-wife duo, who, in collaboration with the University of KwaZulu-Natal, officially launched the Citizen Science Census of the ground-dwelling bird, which takes place on July 19 and 20 throughout KZN.
The couple is working with ecological academics Professor Colleen Downs, Dr Jonah Gula and Dr Nasiphi Bitani to study and generate new data on the species' population status and distribution.
Other North Coast eco-estates, including Palm Lakes, will serve as monitoring sites within the conservation study. The Swiss Ornithological Institute has donated 15 geographic locators to track bird movement.
The LionHeart Experience team is thrilled with the breakthrough. They have been studying and protecting Palm Lakes' biodiversity for years but had not previously encountered the bird.
'This has been a passion project for us for many years,' said Richard.
'We've been searching for the spotted ground thrush in the forests of the estate for the past four years. We always believed it was here.'
Candice noted that the eco-estate is special for wildlife and continues to yield incredible finds.
'The discovery of the spotted ground thrush is significant and extremely important. We hope to monitor its movements and confirm the presence of additional birds in the estate,' she said.
These coastal forest birds breed in the Eastern Cape and Transkei but migrate to KZN during the winter months. BirdLife South Africa and the International Union for Conservation of Nature (IUCN) estimate that only 600 to 1 500 birds remain in the country.
The Tinley Manor eco-estate is now considered a potential refuge for the spotted ground thrush. However, some notable threats remain.
'In forests where we have documented spotted ground thrush, we have found numerous cats roaming the area. This is a real threat to the bird's survival, as is loss of natural habitat through development,' said Richard.
Stay in the loop with The North Coast Courier on Facebook, X, Instagram & YouTube for the latest news.
Mobile users can join our WhatsApp Broadcast Service here or if you're on desktop, scan the QR code below.
At Caxton, we employ humans to generate daily fresh news, not AI intervention. Happy reading!
Stay in the know. Download the Caxton Local News Network App
Stay in the know. Download the Caxton Local News Network App here
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
TimesLIVE
4 days ago
- TimesLIVE
UKZN in bright idea partnership to find load-shedding solutions
The University of KwaZulu-Natal (UKZN) will become the first South African university powered mainly by renewable energy, with 10,000 solar panels across five campuses, in a pilot project that could help Eskom explore ending load-shedding nationwide. The university has signed a pioneering joint venture agreement with Hong Kong-based tech company Youtility to introduce cutting-edge, AI-driven technology to transform how electricity is managed and distributed, with payments handled through a blockchain billing platform. Eskom Distribution will participate in an observational and advisory capacity, positioning UKZN as a national test bed for 'this next-generation energy technology'. UKZN Eskom Power Engineering Programme acting director Prof Leigh Jarvis said the partnership was more than just an energy upgrade. 'It's a strategic transformation of the university's role in South Africa's energy future. Specifically, it means becoming a national leader in renewable energy: UKZN is on track to be the first predominantly renewable-powered university in South Africa, using solar energy, smart microgrids and real-time AI systems. 'One direct outcome is the creation of a UKZN spin-off company focused entirely on developing and supporting energy-related innovations. This venture will serve as a launch pad for commercialising student and staff ideas that address real-world energy challenges,' he said. Jarvis already has plans to feed advanced research into this ecosystem. He intends to incorporate an internationally patented concept involving liquid air energy storage and superconductor devices. 'Students won't just study energy, they'll help manage it, optimise systems and potentially become founders of new tech companies emerging from this initiative. UKZN becomes a living lab where energy solutions can be tested at scale, with national relevance and international export potential. In essence, this partnership makes UKZN not just a user of energy but an active architect of the future energy economy,' Jarvis said. He said the project could reshape the way electricity is generated, distributed and paid for across the country, offering real solutions to national problems such as load-shedding and grid failures. 'By decentralising energy production through microgrids, this approach reduces dependence on the national grid and minimises outages.' The project can also address electricity theft and nonpayment. 'The blockchain billing system makes tampering with meters nearly impossible and ensures people are billed fairly, discouraging illegal connections. In terms of tariff relief, when everyone pays what they should, the cost is spread fairly, and overall tariffs can remain lower. 'If successful, this model can be applied to schools, hospitals, and even rural villages — making energy access more inclusive and equitable. Why now? South Africa is in the middle of an energy crisis. This initiative is not just visionary — it's urgently practical, aligning with national goals for renewable energy, economic upliftment and digital innovation,' said Jarvis. Speaking at the launch event and signing ceremony held at UKZN's Westville campus, acting deputy vice-chancellor for research and innovation at UKZN, Prof Anil Chuturgoon, called it a 'defining moment' in addressing the country's long-standing energy challenges. 'This concept of green energy is going to transform the energy landscape in South Africa,' he said. Youtility director Wayne Mostert said: 'Wizdom is an evolving, AI-driven utility brain with enhanced capabilities which include real-time, decentralised decision-making and smart discharge of power into micro and macro grids.' Drawing parallels with past tech revolutions, Mostert likened Youtility's ambitions to the digital disruption of entertainment media. 'Where Blockbuster failed to adapt, Netflix scaled using data, agility and customer-centricity. Similarly, Youtility is poised to revolutionise the utility sector through sentient, decentralised, and user-empowered infrastructure, creating a new global standard,' he said.
The Citizen
29-06-2025
- The Citizen
Fact-checked: HIV/Aids breakthrough not a ‘cure', popular social media posts misrepresent the facts
While promising, a recent breakthrough in HIV research is not a 'cure' or a 'vaccine', as several posts claim on social media. The scientists involved say it could be many years before the technology is used as a cure. Users on Facebook, Instagram and X have shared the same 'BREAKING NEWS' message, claiming that 'A CURE FOR HIV/AIDS HAS JUST BEEN FOUND'. Africa Check found hundreds of these posts, the most popular of which have been viewed millions of times. The message is typically accompanied by a graphic which includes the text 'Researchers in Australia have just found a cure for HIV/Aids' and an image created using artificial intelligence tools, of a bottle labelled 'HIV Vaccine®'. Unfortunately, this claim is not true. The human immunodeficiency virus, or HIV, is a virus which attacks the immune system, the processes responsible for protecting the body from disease. If left untreated, it causes acquired immunodeficiency syndrome, or Aids. HIV can be treated with antiretroviral drugs, which prevent the virus from multiplying in a person's body. ARV treatment can lower the level of the virus in a person's body to the point that it is undetectable and cannot be transmitted to others. However, ARVs cannot eradicate the virus entirely. So what has prompted these 'breaking news' posts? In this case, there is a real scientific breakthrough behind these claims, but it has been described in a misleading way. Deliberately misleading headline and image shared alongside text copied from genuine news story These posts include paragraphs of text, describing the scientific breakthrough. They begin: A cure for HIV could be a step closer after researchers found a new way to force the virus out of hiding inside human cells. The virus's ability to conceal itself inside certain white blood cells has been one of the main challenges for scientists looking for a cure. It means there is a reservoir of the HIV in the body, capable of reactivation, that neither the immune system nor drugs can tackle. Now researchers from the Peter Doherty Institute for Infection and Immunity in Melbourne, have demonstrated a way to make the virus visible, paving the way to fully clear it from the body. The text is identical to the first 12 paragraphs of a news article published by the UK's Guardian newspaper on 5 June 2025. None of the posts which Africa Check found clearly credited the Guardian as the source, nor did they include the entire article. The original article is headlined: 'Breakthrough in search for HIV cure leaves researchers 'overwhelmed'.' In the posts on social media this has been replaced, usually with a variation on 'Breaking News: A cure for HIV/Aids has just been found', sometimes misspelling Aids as 'Auds'. The Guardian article never refers to the research as a 'cure', but only as a promising step towards one. In sections of the article not included in the social media posts, researchers are quoted as being 'very hopeful' that the breakthrough could eventually be replicated in humans. But this could be a long way off. The Guardian notes: 'The path to using the technology as part of a cure for patients is long and would require successful tests in animals followed by safety trials in humans, likely to take years, before efficacy trials could even begin.' The Guardian links back to the original scientific paper, published in the journal Nature Communications. The paper also does not refer to its findings as a 'cure' for HIV. Although they don't represent a 'cure', the findings are a promising development in HIV research. Promising advancement in research, not HIV cure As already discussed, ARV medications can reduce the presence of HIV in a person's body, but not eradicate the virus entirely. The Nature Communications article covers research into a potential solution to this problem. In their paper and in comments to the Guardian, the University of Melbourne researchers describe a new method of delivering genetic material, known as mRNA, into certain kinds of white blood cells. HIV is able to infect these white blood cells, where it can essentially hide from the body's immune system and other forms of treatment. Being able to reach the virus inside those white blood cells opens up new opportunities to treat it. Vaccines against Covid-19 also made use of mRNA, which may be why the graphic accompanying these 'HIV cure' claims depicts an 'HIV vaccine'. (The image in the graphic is very similar to stock images that have existed since 2016.) The Nature Communications study did not use mRNA to vaccinate against HIV, but demonstrated that 'therapeutic mRNA', such as small pieces of mRNA designed to alert the immune system to the presence of the virus, could be delivered to these white blood cells. At time of writing, there is no cure for HIV/Aids. But besides this breakthrough, there have been other promising developments in HIV treatment. Real breakthroughs in HIV treatment In 2023, a clinical trial began in South Africa and the US to test the efficacy of a potential vaccine against HIV called VIR-1388. Like other vaccines, VIR-1388 would not be a cure for HIV but, if it works, may prevent infection and therefore stop the spread of the disease. It was developed by US-based Vir Biotechnology. ARVs can be taken as pre-exposure prophylaxis, or PrEP, by people who are HIV negative but likely to be exposed to the virus. This can prevent transmission of HIV. However, PrEP must be taken frequently to ensure proper protection. Current South African PrEP guidelines involve taking one pill every day. Lenacapavir is an injectable drug which has been shown to reliably protect against HIV transmission for six months at a time, with some trials demonstrating protection for a full year. After successful trials, there are plans to begin use of the drug in countries such as South Africa, which has a particularly high burden of HIV. It has been approved for use in the US. Like other forms of PrEP, Lenacapavir is neither a 'cure' nor a 'vaccine', but can prevent HIV transmission. Because it is much longer lasting than other forms of PrEP, it may make it much easier to prevent transmission.
eNCA
26-06-2025
- eNCA
Chatbot aimed at women and girls
JOHANNESBURG - NGO Shout It Now has launched an AI companion called AIMEE a WhatsApp chat bot service that offers a space for young women to discuss sexual health challenges. READ: AI chatbot helps victims of digital sexual violence Over 4,500 women and girls have engaged on the platform since its launch in March. Topics vary between contraception, mental health support, sexually transmitted infection, HIV testing or treatment, gender-based violence, and more. Doctor Alex Spyrelis, a Research Coordinator for Shout It Now, discussed this with eNCA.
